Table 2 Baseline characteristics

Total of patients (38)

Male

29 (76.3)

Female

9 (23.7)

Male: female

3.2: 1

Age (years)

38.3 ± 9.5

21–54

P = 0.98

Bilateral

35 (92.1)

Total of eyes (73)

BCVA at presentation

0.7 ± 0.8

0–2.7

P < 0.001*

BCVA at last visit

0.7 ± 0.9

0–4.7

Frequency of attacks

2.1 ± 1.9

1–9

P = 0.336

Duration of Follow up (years)

5.4 ± 4.2

8 mo–17 y

P = 0.091

BOS24-2YR

7.1 ± 7.4

0–33

P < 0.001*

BOS24 (Max)

4.8 ± 4.9

0–22

P < 0.001*

 Anterior chamber cells

0.6 ± 0.9

0–4

P > 0.05

 Vitreous opacity

1.0 ± 1.0

0–4

P > 0.05

 Peripheral fundus lesions

1.3 ± 2.2

0–8

P > 0.05

 Posterior pole lesions

0.9 ± 1.3

0–4

P > 0.05

 Subfoveal lesions

0.6 ± 0.9

0–2

P > 0.05

 Optic disc lesions

0.6 ± 0.9

0–2

P > 0.05